Revolutionary Factors Affecting Pharmaceutical Industry

The world is changing at an ever-increasing pace. Shopping malls have been replaced with online shopping; traditional classrooms have given way to online classes and soon, driving your own car may seem like a nostalgic activity. Pharmaceutical Industry is no different. Pharmaceutical and life sciences companies are facing an upsurge of challenges as a part of what could be the New Health Economy.

The global pharmaceutical industry is said to have a relative growth over the next few years. Be on guard for the following pharmaceutical trends and set the right course for your strategies.

Patient Empowerment

Gone are the days when individuals relied on doctors for diagnosis. Due to the easily accessible information, patients today can learn about their health conditions online and obtain the necessary knowledge to be aware of the available treatments and choose the ones they prefer. Doctors have lost their power to influence this choice and thus pharma companies have to look for new and innovative ways to get their medications sold.

The patient-first business model helps to do just that. The pharma companies which succeed in patient engagement increases their chances of commercial and regulatory success as decisions are taken in accordance with the patient’s needs and results. For productive collaboration with patients, pharma companies are required to find better communication techniques and also invest in more effective data analytics. Although many patients are skeptical about sharing their personal information, an independent survey found that most people are willing to let pharma companies know about their medical activities if it leads to a better care.

Furthermore, Virtual reality is used to motivate consumers to be more active and compassionate. If used as a marketing tool, this can build empathy, enable training on medical devices and create detailed demos that illustrate the mechanism of action with extreme clarity and help facilitate a stronger bond between pharma companies and consumers.

Increase in Biosimilars

Biosimilar products are suspected to continue to have a significant impact on the pharmaceutical industry. Due to the increase in approval of biosimilars and their rapid introduction in the market, market conditions will have to evolve accordingly. This will not only provide patients with numerous treatment options but also have the ability to get drugs for serious disorders at a much cheaper cost than the original biologics. This is an opportunity for manufacturers specializing in generics and biosimilars to grow their business rapidly. It is said to be a very sizeable opportunity and if companies do it correctly, the probability of success is higher than the traditional pharmaceutical approach and the cost of development should be lower than novel drugs.

Precision Medication

Arbitrary costs of trial-and-error therapies and the increasing need for decreasing the cost of healthcare has inspired the transition of one-fits-all model to the outcome-based targeted therapies. Precision medicine eliminates the need for guesswork, variable diagnosis, and generalized treatment strategies. Thus far only a few cases exists which used genetic information to make a decision regarding a suitable treatment.

Currently, the drug development industry is heavily investing in precision medicine. Furthermore, scientific advancements in genomics field suggest that time and costs are no longer a hindrance for precision medicine. Increasing awareness about the human genome and its correlation with disease progression are expected to shift the current focus beyond oncology.

3-D Printed Drugs

3-D printing assures a future of drugs printed on demand with custom doses and the possibility that price may no longer be an obstacle. The first 3-D printed medicine that dissolves rapidly is used for the treatment of epilepsy. Small companies are deriving other solutions for creating drugs that can be metabolized faster and can be marketed more easily. Because of this entire pharma industry will have to be restructured within years, perhaps even months.

Digital Healthcare

The global healthcare industry has seen a transformation which has been driven by advances in biopharmaceutical, medical and surgical procedures and automation. The Digital Health applications in information and communication technologies aid to utilize the full potential of big data analytics and change the healthcare industry. Today, if the pharma companies are not thinking about how to integrate such programs and educational resources and not just use them as a tool to promote, they will be left behind.

The digitization of the patient, from the electronic health records to genome mapping allows for targeted treatment that is revolutionizing healthcare. The introduction of mobile health sensors and wearables offers a real-time insight into a patient’s progress. Furthermore, computers with the ability to easily analyze enormous amounts of data and scientific literature can assist pharma companies in the development of new drugs and improve the existing ones.

Counterfeit Drugs

Counterfeit Drugs are fake medicine. They can be either contaminated or contain the wrong or lack of active compound. Pharma companies are required to track the product ID from manufacturing process and trace its movement throughout the supply chain. These drugs are not just available via the black market, but are also accessible through legitimate pharmacies. Fake drugs are said to be more deadly than terrorism. An independent survey concluded that 200,000 people are killed on an average due to counterfeit drugs.

All of this concludes into the complexity of the supply chain of pharmaceuticals. With an increased dependence on outsourced manufacturers and third party logistics, the lack of clarity across the various components of the supply chain has never been so blurred. This together with the intrinsic demand unpredictability from anywhere in the world and the disparity of supply and demand makes an increasingly volatile value chain.

Factors Affecting Pharmaceutical Industry - Insights Success

The 10 Most Admired Pharma Companies in 2018 march2018 - Insights Success

Best Online Business Magazine in India | Journals For Entrepreneurs - Insights success

Social Media Marketing for Pharmaceutical Industry

Social media infiltrate virtually every facet of an individual’s digital life. Today, patients are using social media as a major source of information and healthcare research. Thus, it is essential that pharma companies should be present on social media to provide full and accurate information to the consumers. To comprehend how social media can assist patients, it is crucial to understand what compels people to use social media as a source of information.

Social media allows interaction among people which involves exchange and creation of information. It is the perfect conduit for pharmaceutical companies to connect with their customers, patients and physicians.

According to the current FDA regulations, pharma companies are not able to easily join in a conversation to provide accurate and balanced information. Regulations dictate that, in a single social post, brands are required to provide precise facts on the benefits and hazards associated with conditions and products. Due to the character limitations on many social media platforms, most pharma companies prefer to stay out of the conversation. This results in circulation of falsified information. This information can be either marginally inaccurate or significantly harmful.

Although the communication of pharmaceutical industries is highly regulated, they are gradually adopting social media platforms to reach and interact with consumers and healthcare professionals. Here are some of the top social media practices to look out for:

Crafting Customer Experience

Several marketers think that their job is finished once the sales team takes over, but in reality, it is just the beginning. The way people experience your brand will impact the way they think about you, which will have an enormous effect on the success of your company in the long run. Devoting a part of the marketing budget to nurture the existing clientele will make their experience splendid and thus promote brand loyalty. It is also crucial to respond whenever your brand in mentioned publicly, whether positively or negatively, which will help cultivate a strong and lasting relationship with your customers. Younger generations are increasingly withdrawing from traditional social media platforms and adopting more innovative channels that are more intimate in the way of communication. To keep up with this challenge, companies need to find a way to automate the process wherever possible.

Regulating Content

Pharma companies need to develop content marketing strategies that merge each piece of content on every channel with their organization’s objectives and customers’ needs. Creators need to have a clear business objective including the value that will be delivered to distinct audiences. All companies need to have a social media compliance officer who will work closely with a corporate legal counsel and develop a complete strategy and decide if there will be consolidated social media posting or if individual employees will have the consent to participate. And lastly, it is critical that all employees understand their role in corporate social media and be trained on the rules.

Overall Integration

Pharma companies should stop thinking about content marketing and social media as add-ons. To boost their outcome for clients, content and social marketing need to be a part of almost every program. To develop a fully integrated program, companies need to involve influencers and content marketers during the initial stages. Implementing an organized approach to content and moderation will not only optimize the processes, but also aid in assuring authorities that all the bases are covered to protect and provide value for the brand.

Investing in Employees

An independent survey discovered that 72% of social media users expect response within an hour from the brands they follow. This has caused brands to start heavily investing in cross-functional social media teams that can keep up with the increasing number of client pings every day. Encouraging and incentivizing team members to share brand messages on their own social media accounts, is predicted to be a game-changer in the coming days. However this cannot be forced, it is essential for employees to want to share company posts, and along with this the content has to resonate with their own audiences.

Influencer Marketing

Influencer marketing will continue to develop and become an even more established part of the strategy. Currently many brands try influencer marketing and fail as it is not easy to find effective influencers. Additional data will help in selection of the right influencers and analyze the results from influencer campaigns. Today, in healthcare, influencers are often regular people. Some are directly affected by a disease or are being treated with a specific product, while others have gained a lot of knowledge about a condition and are considered as Subject Matter Experts. The common trend is to select someone who has an ever-increasing community of followers who value their opinion.

Numerous companies still think of social media as merely a marketing tool which is not true anymore. Consumers learn about products on different social networks and seek customer service on messaging channels. Moreover, good storytelling has always been an essential part of effective marketing. But social media is changing the way audiences consume stories and pharma companies will be required to keep up with the evolution of social storytelling if they want to remain relevant.

Yet there is still a note of caution with compliance being the foremost priority of pharmaceutical companies. But as industries are starting to adopt social media without clear regulatory guidance, remaining compliant will be the main challenge to face.

Social Media Marketing | Pharmaceutical Industry - Insights Success

The 10 Most Admired Pharma Companies in 2018 march2018 - Insights Success

Best Online Business Magazine in India | Journals For Entrepreneurs - Insights success